NASDAQ: NVCTRUSSELL2000
Nuvectis Pharma, Inc.
Healthcare · Biotechnology · Headquartered in Fort Lee, US
Price
Loading chart…
Overview
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Nuvectis Pharma, Inc., its business model, key products, and controversies.